Anthera Pharmaceuticals Inc
OTC:ANTH

Watchlist Manager
Anthera Pharmaceuticals Inc Logo
Anthera Pharmaceuticals Inc
OTC:ANTH
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 2.6k USD

Net Margin
Anthera Pharmaceuticals Inc

0%
Current
-5 607%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-24.9m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Anthera Pharmaceuticals Inc
Glance View

Market Cap
2.6k USD
Industry
Biotechnology

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines to treat serious and life threatening diseases. The company is headquartered in Hayward, California and currently employs 21 full-time employees. The company went IPO on 2010-03-02. The firm has two Phase III product candidates, liprotamase also known as Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy (PERT) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (EPI), often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor (BAFF), which has been shown to be elevated in a range of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), or lupus, Immunoglobulin A nephropathy (IgA) nephropathy, lupus nephritis and others.

ANTH Intrinsic Value
Not Available
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-24.9m
/
Revenue
0
What is the Net Margin of Anthera Pharmaceuticals Inc?

Based on Anthera Pharmaceuticals Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top